Esperion Therapeutics reported $-42989000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4717M 357M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Amarin AMRN:US $ -28.31M 44.44M
Amgen AMGN:US $ 2500M 196M
Biogen BIIB:US $ 610.7M 23.6M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Cytokinetics CYTK:US $ -80.55M 58.85M
Daiichi Sankyo 4568:JP Y -50747M 89777M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Esperion Therapeutics ESPR:US $ -42989000 12.64M
Geron GERN:US $ -28.68M 2.31M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Heron Therapeutics HRTX:US $ -62.92M 9.39M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Intra Cellular Therapies ITCI:US $ -72.66M 13.34M
IONIS PHARMACEUT IONS:US $ -57.5M 278.11M
Merk MRK:US $ 5569M 1994M
Minerva Neurosciences NERV:US $ -7.99M 13.39M
Moderna Inc MRNA:US 4.23B 1.18B
Nektar Therapeutics NKTR:US $ -116.56M 3.65M
Pfizer PFE:US $ 9873M 5297M
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Puma Biotechnology PBYI:US $ -0.76M 7.79M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Seattle Genetics SGEN:US $ -133.05M 39.02M
United Therapeutics UTHR:US $ 286.3M 116.5M
Vanda Pharmaceuticals VNDA:US $ -7.67M 16.3M